Tucson Oncologist Rachna Shroff Died at 47

The University of Arizona physician leaves behind a legacy of advancing research in gastrointestinal cancer treatment.

Updated on Oct. 14, 2026 in Cancer

Bold flat-color editorial illustration of a stone column against a minimalist horizon, representing the institutional legacy of medical research.
Dr. Rachna Shroff, a prominent University of Arizona oncologist and GI cancer research leader, has died at the age of 47. AI Illustration. Upload story photo >

Rachna Shroff, an oncologist at the University of Arizona Cancer Center, passed away in October 2026 at age 47. Her career included significant contributions to cancer research and the development of future clinical talent.

Why it matters

Shroff's work bridged high-level research and clinical practice, notably through her leadership in gastrointestinal oncology and her commitment to fostering the next generation of cancer investigators.

Over her career, Shroff authored more than 80 scientific publications and delivered over 130 professional presentations. She also successfully raised over $1.35 million to establish a dedicated award for young researchers in biliary cancers.

The players

Rachna Shroff

An oncologist who served as chief of the Division of Hematology/Oncology at the University of Arizona College of Medicine-Tucson.

University of Arizona Cancer Center

A comprehensive cancer facility in Tucson providing research, clinical trials, and patient care.

University of Texas MD Anderson Cancer Center

A global leader in cancer research and treatment located in Houston, Texas.

The details

Shroff served as chief of the Division of Hematology/Oncology at the University of Arizona College of Medicine-Tucson, focusing heavily on gastrointestinal oncology. Her approach combined rigorous clinical investigation with broad educational outreach, including chairing the 2024 GI ASCO conference. She prioritized long-term oncology development by launching the Conquer Cancer-Rachna Shroff FASCO Endowed Young Investigator Award in September 2026 to support early-career clinicians.

Timeline

  1. 1993: Received the Osler Fellowship.

  2. 2010: Completed a fellowship at the University of Texas MD Anderson Cancer Center.

  3. 2018: Joined the University of Arizona faculty.

  4. 2024: Chaired the GI ASCO gastrointestinal cancer conference.

  5. September 2026: Launched an endowed young investigator award.

Health Landscape

Shroff was a central participant in the GI ASCO gastrointestinal cancer conference, which coordinates international efforts to improve biliary cancer outcomes. Her career reflects the ongoing transition toward specialized, grant-supported research models in modern oncology.

Patients and families looking to understand the latest developments in gastrointestinal cancer treatment may consult their oncology care teams about current clinical trial opportunities supported by institutions like the University of Arizona. These discussions are valuable for identifying standard-of-care options versus emerging research therapies.

The takeaway

Shroff's career emphasizes the vital role of sustained academic mentorship in advancing clinical oncology for complex diseases. Patients are encouraged to ask their physicians about ongoing research programs when seeking specialized care for gastrointestinal conditions.

Further reading

For updates on regional oncology advancements, visit Cancer.